Bison Wealth LLC Sells 632 Shares of The Clorox Company (NYSE:CLX)

Bison Wealth LLC trimmed its holdings in The Clorox Company (NYSE:CLX) by 15.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,363 shares of the company’s stock after selling 632 shares during the period. Bison Wealth LLC’s holdings in Clorox were worth $546,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Integral Investment Advisors Inc. grew its holdings in shares of Clorox by 4.1% in the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after purchasing an additional 67 shares during the last quarter. HCR Wealth Advisors increased its holdings in Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after buying an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC grew its stake in shares of Clorox by 6.1% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock valued at $218,000 after acquiring an additional 77 shares during the period. Wedbush Securities Inc. raised its stake in Clorox by 1.2% during the 4th quarter. Wedbush Securities Inc. now owns 7,624 shares of the company’s stock valued at $1,238,000 after purchasing an additional 94 shares during the period. Finally, Brooklyn Investment Group boosted its stake in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Trading Up 0.7 %

CLX opened at $142.15 on Thursday. The stock has a market capitalization of $17.51 billion, a PE ratio of 38.84, a P/E/G ratio of 2.62 and a beta of 0.61. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The firm’s fifty day moving average price is $144.83 and its 200 day moving average price is $155.29. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the business posted $2.16 EPS. As a group, research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.43%. Clorox’s payout ratio is 133.33%.

Wall Street Analyst Weigh In

CLX has been the subject of several research analyst reports. Barclays decreased their target price on Clorox from $139.00 to $134.00 and set an “underweight” rating for the company in a research report on Friday, April 11th. DA Davidson reduced their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Wells Fargo & Company decreased their target price on shares of Clorox from $155.00 to $145.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 16th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $153.83.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.